Back to Rankings

NRXP

NRXD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
Current thesis
The primary-source picture improved modestly: Q1 revenue of about $1.1 million from Dura, net loss narrowed to about $1.4 million from $5.5 million a year earlier, and post-quarter ATM proceeds added roughly $7.0 million of cash support. If KETAFREE reaches a Summer 2026 approval path and NRX-100 is filed in Q2 2026, the stock could re-rate from a low base.
Posture
Defensive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta +10.0.
What can break
HOPE and Dura integration add execution risk because the current revenue base is still small and depends on successful clinic expansion and operational scaling. [#10-Q-2026-05-15]
Momentum
84
Value
41
Sentiment
28
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $3.40 · Bull $6.00 · Bear $1.50
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-16 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $42.00
Why
Momentum84 · Δ7d +10.0
Value41 · Δ7d -0.1
Sentiment28 · Δ7d -3.7
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Momentum · See technicals
Momentum
84
26% active weight
Current posture
7d trendSoftening
Δ7d
+10.0
Δ21d
-11.4
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
0.0
Sentiment
28
34% active weight
Current posture
7d trendSoftening
Δ7d
-3.7
Δ21d
-12.8
Why this grade

Composite grade D. Momentum 83.8 / Value 41.1 / Sentiment 27.9

Fundamentals (TTM)
As of 2026-07-17
Market Cap
$179.1M
Beta
1.92
Shares Out
41.94M
P/E (TTM) · Derived
-3.2
P/S (TTM)
279.82
P/FCF (TTM) · Derived
-7.06
Rev YoY
-
EPS YoY
-86.8%
Gross Margin
+37.1%
Op Margin
-8026.0%
Net Debt
-$7.17M
Current Ratio
0.29
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology